Unity Biotechnology, Inc. (UBX) Misses Q1 EPS by 59c
Tweet
Share
E-mailGet Alerts UBX Hot Sheet
Join SI Premium – FREE
Unity Biotechnology, Inc. (NASDAQ: UBX) reported Q1 EPS of ($0.76), $0.59 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Unity Biotechnology, Inc. (UBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
- Donerail urges Beazer Homes board to engage with DFH's $32 offer
- Applied Materials surges as CEO signals multi-year chip boom
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
